Title: Pre- and postsynaptic alpha-adrenergic effects of the antihypertensive drug budralazine.
Journal: Arzneimittel-Forschung 19810101
56173-18-3
1189902-21-3 | Carbamazepine-d2 (Major) | AA01CCDB
52610-77-2 | 2,6,10,14,18,22,26,30,34-Hexatriacontanonaene,1-bromo-3,7,11,15,19,23,27,31,35-nonamethyl-,(2E,6E,10E,14E,18E,22E,26E,30E)- | AA01CCG6 | MFCD07772443
1329652-13-2 | γ-Tocopherol-d4 (major) | AA01CCKC
1426047-01-9 | 2-(2,4-Difluorophenyl)-5-fluoropyridine | AA01CJWI | MFCD31692240
1189118-20-4 | 1-tert-butyl 4-ethyl 4-phenylpiperidine-1,4-dicarboxylate | AA01DDHW | MFCD12032167
1211592-89-0 | 1-bromo-3-(1-methylcyclopropyl)benzene | AA01DDWW | MFCD11109731
112233-74-6 | N2-Acetyl-o6-(diphenylcarbamoyl)guanine | AA01DG0S | MFCD01630925
1546210-99-4 | 4-Acetyl-2-(2,5-dimethylphenoxy) pyridine | AA01DHAT | MFCD22939878
73181-56-3 | 2-[[(1,1-Dimethylethoxy)carbonyl]amino]-alpha-oxo-4-thiazoleacetic acid | AA01DIE8 | MFCD18074182
1349718-80-4 | 4-Bromo-5-isopropyl-2-methyl-2H-pyrazol-3-ylamine | AA01DK2S | MFCD08669411